Low power and striking results – a surprise but not a paradox

New England Journal of Medicine

Volumn 332, Issue 16, 1995, Pages 1091-1092

  Walker, Alexander M ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISONE; VINCRISTINE;

BONE MARROW TRANSPLANTATION; EDITORIAL; GRAFT REJECTION; HUMAN; MEDICAL DECISION MAKING; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; TREATMENT OUTCOME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW TRANSPLANTATION; CONFIDENCE INTERVALS; CYCLOPHOSPHAMIDE; DATA INTERPRETATION, STATISTICAL; DOXORUBICIN; HUMAN; LYMPHOMA, NON-HODGKIN; PREDNISONE; TREATMENT OUTCOME; VINCRISTINE;

EID: 0028906373     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199504203321609     Document Type: Editorial

References (2)

1. Verdonck LF, van Putten WLJ, Hagenbeek A, Comparison of chop chemotherapy with autologous bone marrow transplantation for slowly responding patients with aggressive non-Hodgkin's lymphoma. N Engl J Med 1995; 332: 1045-1051
2. Rothman KJ A show of confidence. N Engl J Med 1978; 299: 1362-1363